Texas Permanent School Fund’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-39,495
Closed -$158K 1527
2019
Q4
$158K Buy
39,495
+269
+0.7% +$1.26K ﹤0.01% 1499
2019
Q3
$192K Buy
39,226
+689
+2% +$3.85K ﹤0.01% 1477
2019
Q2
$235K Buy
38,537
+106
+0.3% +$563 ﹤0.01% 1453
2019
Q1
$223K Buy
38,431
+1,392
+4% +$14.4K ﹤0.01% 1471
2018
Q4
$499K Buy
37,039
+1,458
+4% +$24.6K 0.01% 1271
2018
Q3
$691K Buy
35,581
+4,481
+14% +$95.4K 0.01% 1238
2018
Q2
$795K Sell
31,100
-772
-2% -$18K 0.01% 1200
2018
Q1
$642K Sell
31,872
-717
-2% -$16.7K 0.01% 1247
2017
Q4
$654K Sell
32,589
-2,316
-7% -$45.5K 0.01% 1262
2017
Q3
$723K Buy
34,905
+3,015
+9% +$51K 0.01% 1249
2017
Q2
$472K Buy
31,890
+470
+1% +$7.83K 0.01% 1357
2017
Q1
$501K Buy
31,420
+164
+0.5% +$2.37K 0.01% 1326
2016
Q4
$394K Sell
31,256
-1,612
-5% -$30K 0.01% 1394
2016
Q3
$921K Buy
32,868
+5,122
+18% +$172K 0.01% 1116
2016
Q2
$971K Buy
27,746
+2,500
+10% +$78.6K 0.01% 1079
2016
Q1
$692K Buy
+25,246
New +$743K 0.01% 1211

Other funds holding DPLO

Texas Permanent School Fund's DPLO Position: Q1 2020 in Review

Texas Permanent School Fund sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 39,495 shares — an estimated $158K sold.

Texas Permanent School Fund first reported a position in DPLO in Q1 2016 and held it in 16 quarters. The position peaked at $971K in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Texas Permanent School Fund reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Texas Permanent School Fund sold 39,495 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $158K.
  • Texas Permanent School Fund first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 16 quarters.
  • Texas Permanent School Fund's DIPLOMAT PHARMACY, INC. position peaked at $971K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Texas Permanent School Fund's 13F filing for Q1 2020, filed 27 Apr 2020.